Alex Martin Martin

John Alexander Martin is currently Chief Executive Officer & Director at Abcuro, Inc., Chief Executive Officer & Director at Palladio Biosciences, Inc. since 2019, and Chairman at Veralox Therapeutics, Inc. since 2020.
Former positions include Chief Executive Officer at Affectis Pharmaceuticals AG in 2010, Chief Executive Officer at Realm Therapeutics, Inc. from 2015 to 2019, Director at Active With Me, Inc., Associate Director-Diabetes Products at GlaxoSmithKline LLC, Independent Director at Actavia Life Sciences, Inc. from 2016 to 2019, Managing Director at The Sophocles Group LLC from 2009 to 2011, Independent Director at ESSA Pharma, Inc. from 2019 to 2025, Vice President-Business Development at Unigene Laboratories, Inc. from 2010 to 2011, Executive VP-Pharmaceutical Sales & Marketing at Medscape, Inc., Chief Financial & Business Officer at BioXell SpA from 2003 to 2007, Chief Operating Officer at Intercept Pharmaceuticals, Inc. from 2007 to 2009, Senior Vice President-Corporate Development at Moksha8 Pharmaceuticals, Inc. from 2011 to 2015, VP-Global Business Development & Licensing at Novartis Pharmaceuticals Corp.
from 2001 to 2003, and VP-Global Business Development & Licensing at Smithkline Beecham Pharmaceuticals (Canada).
Education includes an undergraduate degree from Cornell University in 1989 and an MBA from Harvard Business School.